http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106668032-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7390d83907b6a5043c4aa685e25c77ff |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-59 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-663 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-28 |
filingDate | 2015-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_39c4012abd36de4fe2419be7b84464ec |
publicationDate | 2017-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-106668032-A |
titleOfInvention | Tablet containing alendronate sodium and preparation thereof |
abstract | The invention belongs to the technical field of medicine and concretely relates to a tablet containing difficultly soluble alendronate sodium and a preparation thereof. The tablet is composed of alendronate sodium, vitamin D, a diluent, a solubilizer, a lubricant, a disintegrant and other acceptable pharmaceutical excipients. The tablet containing alendronate sodium can reduce the irritation of the drug, improve the dissolution of the drug, improve the patient's medication compliance and effectively improve the quality of life of patients with osteoporosis. The preparation method is simple, is easy to operate, is suitable for industrial production, is safe and effective and realizes quality control. |
priorityDate | 2015-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 75.